Long-Term Risk Assessment for Medical Application of Cold Atmospheric Pressure Plasma

Despite increasing knowledge gained based on multidisciplinary research, plasma medicine still raises various questions regarding specific effects as well as potential risks. With regard to significant statements about in vivo applicability that cannot be prognosticated exclusively based on in vitro...

Full description

Bibliographic Details
Main Authors: Rico Rutkowski, Georg Daeschlein, Thomas von Woedtke, Ralf Smeets, Martin Gosau, Hans-Robert Metelmann
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/10/4/210
_version_ 1797570810853982208
author Rico Rutkowski
Georg Daeschlein
Thomas von Woedtke
Ralf Smeets
Martin Gosau
Hans-Robert Metelmann
author_facet Rico Rutkowski
Georg Daeschlein
Thomas von Woedtke
Ralf Smeets
Martin Gosau
Hans-Robert Metelmann
author_sort Rico Rutkowski
collection DOAJ
description Despite increasing knowledge gained based on multidisciplinary research, plasma medicine still raises various questions regarding specific effects as well as potential risks. With regard to significant statements about in vivo applicability that cannot be prognosticated exclusively based on in vitro data, there is still a deficit of clinical data. This study included a clinical follow-up of five probands who had participated five years previously in a study on the influence of cold atmospheric pressure plasma (CAP) on the wound healing of CO<sub>2</sub> laser-induced skin lesions. The follow-up included a complex imaging diagnostic involving dermatoscopy, confocal laser scanning microscopy (CLSM) and hyperspectral imaging (HSI). Hyperspectral analysis showed no relevant microcirculatory differences between plasma-treated and non-plasma-treated areas. In summary of all the findings, no malignant changes, inflammatory reactions or pathological changes in cell architecture could be detected in the plasma-treated areas. These unique in vivo long-term data contribute to a further increase in knowledge about important safety aspects in regenerative plasma medicine. However, to confirm these findings and secure indication-specific dose recommendations, further clinical studies are required.
first_indexed 2024-03-10T20:31:40Z
format Article
id doaj.art-1d6099e6043a4d74ad2f9e6bfa93ee13
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T20:31:40Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-1d6099e6043a4d74ad2f9e6bfa93ee132023-11-19T21:21:54ZengMDPI AGDiagnostics2075-44182020-04-0110421010.3390/diagnostics10040210Long-Term Risk Assessment for Medical Application of Cold Atmospheric Pressure PlasmaRico Rutkowski0Georg Daeschlein1Thomas von Woedtke2Ralf Smeets3Martin Gosau4Hans-Robert Metelmann5Department of Oral and Maxillofacial Surgery, University Medicine Hamburg-Eppendorf, 20251 Hamburg, GermanyDepartment of Dermatology, University Medicine Greifswald, 17475 Greifswald, GermanyLeibniz Institute for Plasma Science and Technology (INP) e.V. Greifswald, 17489 Greifswald, GermanyDepartment of Oral and Maxillofacial Surgery, University Medicine Hamburg-Eppendorf, 20251 Hamburg, GermanyDepartment of Oral and Maxillofacial Surgery, University Medicine Hamburg-Eppendorf, 20251 Hamburg, GermanyDepartment of Oral and Maxillofacial Surgery/Plastic Surgery, University Medicine Greifswald, 17475 Greifswald, GermanyDespite increasing knowledge gained based on multidisciplinary research, plasma medicine still raises various questions regarding specific effects as well as potential risks. With regard to significant statements about in vivo applicability that cannot be prognosticated exclusively based on in vitro data, there is still a deficit of clinical data. This study included a clinical follow-up of five probands who had participated five years previously in a study on the influence of cold atmospheric pressure plasma (CAP) on the wound healing of CO<sub>2</sub> laser-induced skin lesions. The follow-up included a complex imaging diagnostic involving dermatoscopy, confocal laser scanning microscopy (CLSM) and hyperspectral imaging (HSI). Hyperspectral analysis showed no relevant microcirculatory differences between plasma-treated and non-plasma-treated areas. In summary of all the findings, no malignant changes, inflammatory reactions or pathological changes in cell architecture could be detected in the plasma-treated areas. These unique in vivo long-term data contribute to a further increase in knowledge about important safety aspects in regenerative plasma medicine. However, to confirm these findings and secure indication-specific dose recommendations, further clinical studies are required.https://www.mdpi.com/2075-4418/10/4/210wound healingreactive oxygen speciescold atmospheric pressure plasmahyperspectral imagingconfocal laser scanning microscopy
spellingShingle Rico Rutkowski
Georg Daeschlein
Thomas von Woedtke
Ralf Smeets
Martin Gosau
Hans-Robert Metelmann
Long-Term Risk Assessment for Medical Application of Cold Atmospheric Pressure Plasma
Diagnostics
wound healing
reactive oxygen species
cold atmospheric pressure plasma
hyperspectral imaging
confocal laser scanning microscopy
title Long-Term Risk Assessment for Medical Application of Cold Atmospheric Pressure Plasma
title_full Long-Term Risk Assessment for Medical Application of Cold Atmospheric Pressure Plasma
title_fullStr Long-Term Risk Assessment for Medical Application of Cold Atmospheric Pressure Plasma
title_full_unstemmed Long-Term Risk Assessment for Medical Application of Cold Atmospheric Pressure Plasma
title_short Long-Term Risk Assessment for Medical Application of Cold Atmospheric Pressure Plasma
title_sort long term risk assessment for medical application of cold atmospheric pressure plasma
topic wound healing
reactive oxygen species
cold atmospheric pressure plasma
hyperspectral imaging
confocal laser scanning microscopy
url https://www.mdpi.com/2075-4418/10/4/210
work_keys_str_mv AT ricorutkowski longtermriskassessmentformedicalapplicationofcoldatmosphericpressureplasma
AT georgdaeschlein longtermriskassessmentformedicalapplicationofcoldatmosphericpressureplasma
AT thomasvonwoedtke longtermriskassessmentformedicalapplicationofcoldatmosphericpressureplasma
AT ralfsmeets longtermriskassessmentformedicalapplicationofcoldatmosphericpressureplasma
AT martingosau longtermriskassessmentformedicalapplicationofcoldatmosphericpressureplasma
AT hansrobertmetelmann longtermriskassessmentformedicalapplicationofcoldatmosphericpressureplasma